Common fragile site FRA11G and rare fragile site FRA11B at 11q23.3 encompass distinct genomic regions

Genes Chromosomes and Cancer

Volumn 46, Issue 1, 2007, Pages 98-106

  Fechter, Anne ^a   Buettel, Isabel ^a   Kuehnel, Elisabeth ^a   Savelyeva, Larissa ^a   Schwab, Manfred ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHROMOSOME 11Q; CHROMOSOME BREAKAGE; CHROMOSOME FRAGILE SITE; CHROMOSOME MUTATION; DNA SEQUENCE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; HUMAN; HUMAN CELL; MARKER GENE; PHENOTYPE; PRIORITY JOURNAL; SOMATIC MUTATION;

BREAST NEOPLASMS; CHROMOSOME FRAGILE SITES; CHROMOSOME FRAGILITY; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 11; CLONING, MOLECULAR; FEMALE; GENES, REPORTER; GENOME, HUMAN; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MODELS, GENETIC; MUTAGENESIS, INSERTIONAL; TUMOR CELLS, CULTURED; VIRUS INTEGRATION;

EID: 33751093051     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20389     Document Type: Article

References (50)

1. Arlt MF, Miller DE, Beer DG, Glover TW. 2002. Molecular characterization of FRAXB and comparative common fragile site instability in cancer cells. Genes Chromosomes Cancer 33:82-92.
2. Ark MF, Xu B, Durkin SG, Casper AM, Kastan MB, Glover TW. 2004. BRCA1 is required for common-fragile-site stability via its G2/M checkpoint function. Mol Cell Biol 24:6701-6709.
3. Berger R, Bloomfield CD, Sutherland R. 1985. Report of the Committee on chromosome rearrangements in neoplasia and on fragile sites. Cytogenet Cell Genet 40:490-535.
4. Bester AC, Schwartz M, Schmidt M, Garrigue A, Hacein-Bey-Abina S, Cavazzana-Calvo M, Ben-Porat N, Von Kalle C, Fischer A, Kerem B. 2006. Fragile sites are preferential targets for integrations of MLV vectors in gene therapy. Gene Ther 13:1057-1059.
5. Bruun D, Folias A, Akkari Y, Cox Y, Olson S, Moses R. 2003. siRNA depletion of BRCA1, but not BRCA2, causes increased genome instability in Fanconi anemia cells. DNA Repair 2:1007-1013.
6. Büttel I, Fechter A, Schwab M. 2004. Common fragile sites and cancer: Targeted cloning by insertional mutagenesis. Ann N Y Acad Sci 1028:14-27.
7. Callahan G, Denison SR, Phillips LA, Shridhar V, Smith DI. 2003. Characterization of the common fragile site FRA9E and its potential role in ovarian cancer. Oncogene 22:590-601.
8. Casper AM, Nghiem P, Arlt MF, Glover TW. 2002. ATR regulates fragile site stability. Cell 111:779-789.
9. Connolly KC, Gabra H, Millwater CJ, Tavlor KJ, Rabiasz GJ, Watson JE, Smyth JF, Wyllie AH, Jodrell DI. 1999. Identification of a region of frequent loss of heterozygosity at 11q24 in colorectal cancer. Cancer Res 59:2806-2809.
10. Durkin SG, Arlt MF, Howlett NG, Glover TW. 2006. Depletion of CHK1, but not CHK2, induces chromosomal instability and breaks at common fragile sites. Oncogene 25:4381-4388.
11. Elstrodt F, Hollestelle A, Nagel JH, Gorin M, Wasielewski M, van den Ouweland A, Merajver SD, Ethier SP, Schutte M. 2006. BRCA1 mutation analysis of 41 human breast cancer cell lines reveals three new deleterious mutants. Cancer Res 66:41-45.
12. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, McGovern R, Gostout BS, Cheung TH, Chung TK, Fu WY, Smith DI. 2003. Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 22:7233-7242.
13. Gabra H, Watson JE, Taylor KJ, Mackay J, Leonard RC, Steel CM, Porteous DJ, Smyth JF. 1996. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Cancer Res 56:950-954.
14. Glover W. 2006. Common fragile sites. Cancer Lett 232:4-12.
15. Glover TW, Arlt MF, Casper AM, Durkin SG. 2005. Mechanisms of common fragile site instability. Hum Mol Genet 14:197-205.
16. Goldberg EK, Glendening JM, Karanjawala Z, Sridhar A, Walker GJ, Hayward NK, Rice AJ, Kurera D, Tebha Y, Fountain JW. 2000. Localization of multiple melanoma tumor-suppressor genes on chromosome 11 by use of homozygosity mapping-of-deletions analysis. Am J Hum Genet 67:417-431.
17. Gollin SM, Bock HG, Caskey CT, Ledbetter DH. 1985. A new family with fra(10)(q25): Spontaneous expression and 100% expression with 100 μM BrdU. Am J Med Genet 21:643-648.
18. Grimwade D, Biondi A, Mozziconacci MJ, Hagemeijer A, Berger R, Neat M, Howe K, Dastugue N, Jansen J, Radford-Weiss I, Lo Coco F, Lessard M, Hernandez JM, Delabesse E, Head D, Liso V, Sainty D, Flandrin G, Solomon E, Birg F, Lafage-Pochitaloff M. 2000. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): Results of the European Working Party. Groupe Francais de Cytogenetique Hematologiqueq, Groupe de Francais d'Hematologie Cellulaire, UK Cancer Cytogenetics Group and BIOMED 1 European Community-Concerted Action "Molecular Cytogenetic Diagnosis in Haematological Malignancies". Blood 96:1297-1308.
19. Guo C, White PS, Weiss MJ, Hogarty MD, Thompson PM, Stram DO, Gerbing R, Matthay KK, Seeger RC, Brodeur GM, Maris JM. 1999. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene 18:4948-4957.
20. Henegariu O, Bray-Ward P, Ward DC. 2000. Custom fluorescent-nucleotide synthesis as an alternative method for nucleic acid labeling. Nat Biotechnol 18:345-348.
21. Hewett DR, Handt O, Hobson L, Mangelsdorf M, Eyre HJ, Baker E, Sutherland GR, Schuffenhauer S, Mao JI, Richards RI. 1998. FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol Cell 1:773-781.
22. Hormozian F, Schmitt JG, Sagulenko E, Schwab M, Savelyeva L. 2006. FRA1E common fragile site breaks map within a 370 kilo-base pair region and disrupt the dihydropyrimidine dehydrogenase gene (DPYD). Cancer Lett [Epub ahead of print].
23. Howlett NG, Taniguchi T, Durkin SG, D'Andrea AD, Glover TW. 2005. The Fanconi anemia pathway is required for the DNA replication stress response and for the regulation of common fragile site stability. Hum Mol Genet 14:693-701.
24. Jones C, Penny L, Mattina T, Yu S, Baker E, Voullaire L, Langdon WY, Sutherland GR, Richards RI, Tunnacliffe A. 1995. Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature 376:145-149.
25. Jones C, Slijepcevic P, Marsh S, Baker E, Langdon WY, Richards RI, Tunnacliffe A. 1994. Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet 3:2123-2130.
26. Koreth J, Bakkenist CJ, McGee O. 1997. Allelic deletions at chromosome 11q22-q23.1 and 11q25-qterm are frequent in sporadic breast but not colorectal cancers. Oncogene 14:431-437.
27. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-1714.
28. Kurahashi H, Emanuel S. 2001. Long AT-rich palindromes and the constitutional t(11;22) breakpoint. Hum Mol Genet 10:2605-2617.
29. Matzner I, Savelyeva L, Schwab M. 2003. Preferential integration of a transfected marker gene into spontaneously expressed fragile sites of a breast cancer cell line. Cancer Lett 189:207-219.
30. Miguez L, Fuster C, Perez MM, Miro R, Egozcue J. 1991. Spontaneous chromosome fragility in chorionic villus cells. Early Hum Dev 26:93-99.
31. Mishmar D, Rabat A, Scherer SW, Nyakatura G, Hinzmann B, Kohwi Y, Mandel-Gutfroind Y, Lee JR, Drescher B, Sas DE, Margalit H, Platzer M, Weiss A, Tsui LC, Roserithal A, Kerem B. 1998. Molecular characterization of a common fragile site (FRA7H) on human chromosome 7 by the cloning of a simian virus 40 integration site. Proc Natl Acad Sci USA 95:8141-8146.
32. Murakami Y. 2005. Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis. Cancer Sci 96:543-552.
33. Musio A, Montagna C, Mariani T, Tilenni M, Focarelli ML, Brait L, Indino E, Benedetti PA, Chessa L, Albertini A, Ried T, Vezzoni P. 2005. SMC1 involvement in fragile site expression. Hum Mol Genet 14:525-533.
34. O'Sullivan MJ, Rader JS, Gerhard DS, Li Y, Trinkaus KM, Gersell DJ, Huettner PC. 2001. Loss of heterozygosity at 11q23.3 in vasculoinvasive and metastatic squamous cell carcinoma of the cervix. Hum Pathol 32:475-478.
35. Petzmann S, Ullmann R, Kiemen H, Renner H, Popper HH. 2001. Loss of heterozygosity on chromosome arm 11q in lung carcinoids. Hum Pathol 32:333-338.
36. Popescu NC, Zimonjic D, DiPaolo JA. 1990. Viral integration, fragile sites, and proto-oncogenes in human neoplasia. Hum Genet 84:383-386.
37. Rasio D, Negrini M, Manemi G, Dragani TA, Croce CM. 1995. Loss of heterozygosity at chromosome 11q in lung adenocarcinoma: Identification of three independent regions. Cancer Res 55:3988-3991.
38. Rassool FV, Le Beau MM, Shen ML, Neilly ME, Espinosa R, III, Ong ST, Boldog F, Drabkin H, McCarroll R, McKeithan TW. 1996. Direct cloning of DNA sequences from the common fragile site region at chromosome band 3p14.2. Genomics 35:109-117.
39. Rassool FV, McKeithan TW, Neilly ME, van Melle E, Espinosa R, III; Le Beau MM. 1991. Preferential integration of marker DNA into the chromosomal fragile site at 3p14: An approach to cloning fragile sites. Proc Natl Acad Sci USA 88:6657-6661.
40. Rozier L, El-Achkar E, Apiou F, Debatisse M. 2004. Characterization of a conserved aphidicolin-sensitive common fragile site at human 4q22 and mouse 6Cl: Possible association with an inherited disease and cancer. Oncogene 23:6872-6880.
41. Savelyeva L, Sagulenko E, Schmitt JG, Schwab M. 2006. The neurobeachin gene spans the common fragile site FRA13A. Hum Genet 118:551-558.
42. Schwartz M, Zlotorynski E, Goldberg M, Ozeri E, Rahat A, le Sage C, Chen BP, Chen DJ, Agami R, Kerem B. 2005. Homologous recombination and nonhomologous end-joining repair pathways regulate fragile site stability. Genes Dev 19:2715-2726.
43. Schwartz M, Zlotorynski E, Kerem B. 2006. The molecular basis of common and rare fragile sites. Cancer Lett 232:13-26.
44. Taylor AM, Bundey S. 1983. Spontaneous expression of the chromosome fragile site fra(10)(q25). Am J Hum Genet 35:123-125.
45. Thorland EC, Myers SL, Persing DH, Sarkar G, McGovern RM, Gostout BS, Smith DI. 2000. Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60:5916-5921.
46. Tomlinson IP, Nicolai H, Solomon E, Bodmer WF. 1996. The frequency and mechanism of loss of heterozygosity on chromosome 11q in breast cancer. J Pathol 180:38-43.
47. Westermann F, Schwab M. 2002. Genetic parameters of neuroblastomas. Cancer Lett 184:127-147.
48. Yu S, Mangelsdorf M, Hewett D, Hobson L, Baker E, Eyre HJ, Lapsys N, Le Paslier D, Doggett NA, Sutherland GR, Richards RI. 1997. Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell 88:367-374.
49. Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS. 2005. Fine mapping and evaluation of candidate genes for cervical cancer on 11q23. Genes Chromosomes Cancer 43:95-103.
50. Zlotorynski E, Rahat A, Skaug J, Ben-Porat N, Ozeri E, Hershberg R, Levi A, Scherer SW, Margalit H, Kerem B. 2003. Molecular basis for expression of common and rare fragile sites. Mol Cell Biol 23:7143-7151.